% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Wang:137616,
author = {X. Wang and A. T. Chan and M. L. Slattery and J.
Chang-Claude$^*$ and J. D. Potter and S. Gallinger and B.
Caan and J. W. Lampe and P. A. Newcomb and N. Zubair and L.
Hsu and R. E. Schoen and M. Hoffmeister$^*$ and H.
Brenner$^*$ and L. Le Marchand and U. Peters and E. White},
title = {{I}nfluence of {S}moking, {B}ody {M}ass {I}ndex, and
{O}ther {F}actors on the {P}reventive {E}ffect of
{N}onsteroidal {A}nti-{I}nflammatory {D}rugs on {C}olorectal
{C}ancer {R}isk.},
journal = {Cancer research},
volume = {78},
number = {16},
issn = {1538-7445},
address = {Philadelphia, Pa.},
publisher = {AACR},
reportid = {DKFZ-2018-01496},
pages = {4790 - 4799},
year = {2018},
abstract = {Nonsteroidal anti-inflammatory drugs' (NSAID) use has
consistently been associated with lower risk of colorectal
cancer; however, studies showed inconsistent results on
which cohort of individuals may benefit most. We performed
multivariable logistic regression analysis to systematically
test for the interaction between regular use of NSAIDs and
other lifestyle and dietary factors on colorectal cancer
risk among 11,894 cases and 15,999 controls. Fixed-effects
meta-analyses were used for stratified analyses across
studies for each risk factor and to summarize the estimates
from interactions. Regular use of any NSAID, aspirin, or
nonaspirin NSAIDs was significantly associated with a lower
risk of colorectal cancer within almost all subgroups.
However, smoking status and BMI were found to modify the
NSAID-colorectal cancer association. Aspirin use was
associated with a $29\%$ lower colorectal cancer risk among
never-smokers [odds ratios (OR) = 0.71; $95\%$ confidence
intervals (CI): 0.64-0.79], compared with $19\%$ and $17\%$
lower colorectal cancer risk among smokers of pack-years
below median (OR, 0.81; $95\%$ CI, 0.71-0.92) and above
median (OR, 0.83; $95\%$ CI, 0.74-0.94), respectively (P
interaction = 0.048). The association between any NSAID use
and colorectal cancer risk was also attenuated with
increasing BMI (P interaction = 0.075). Collectively, these
results suggest that obese individuals and heavy smokers are
unlikely to benefit as much as other groups from the
prophylactic effect of aspirin against colorectal
cancer.Significance: Obesity and heavy smoking attenuate the
benefit of aspirin use for colorectal cancer prevention.
Cancer Res; 78(16); 4790-9. ©2018 AACR.},
cin = {C020 / C070 / G110 / L101},
ddc = {610},
cid = {I:(DE-He78)C020-20160331 / I:(DE-He78)C070-20160331 /
I:(DE-He78)G110-20160331 / I:(DE-He78)L101-20160331},
pnm = {313 - Cancer risk factors and prevention (POF3-313)},
pid = {G:(DE-HGF)POF3-313},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:29921691},
pmc = {pmc:PMC6095723},
doi = {10.1158/0008-5472.CAN-18-0326},
url = {https://inrepo02.dkfz.de/record/137616},
}